Search results
Results From The WOW.Com Content Network
Researcher working with the Ebola virus while wearing a BSL-4 positive pressure suit. There is a cure for the Ebola virus disease that is currently approved for market the US government has inventory in the Strategic National Stockpile. [1] For past and current Ebola epidemics, treatment has been primarily supportive in nature. [2]
The trial enrolled pediatric and adult participants (including pregnant women) with Zaire ebolavirus infection. [3] All participants received standard, supportive care for the disease. [3] The participants and the health care providers knew which treatment was being given. [3] The primary efficacy endpoint was 28-day mortality. [2]
A number of companies were expected to develop Ebola vaccines: GlaxoSmithKline, NewLink Genetics, Johnson & Johnson, and Bavarian Nordic. [82] Another company, Emergent BioSolutions, was a contestant for manufacturing new doses of ZMapp, [citation needed] a drug for Ebola virus disease treatment originally developed by Mapp Biopharmaceutical. [83]
The Ervebo vaccine, developed by Merck, is a single-dose vaccine. It works by using a modified virus to produce antibodies against Ebola, equipping the immune system to recognise and neutralise ...
A stockpile of half-a-million Ebola vaccine doses was established by Gavi and other global health partners in 2019 for use in outbreaks of haemorrhagic fever, which has an average fatality rate of ...
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication used for the treatment of Zaire ebolavirus (Ebolavirus) infection. [2] [3]The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.
In fact, the nature of Ebola - which is spread by close contact with bodily fluids and blood - means that any modern hospital using standard, rigorous, infection-control measures should be able to ...
Post-Ebola virus syndrome (or post-Ebola syndrome) is a post-viral syndrome affecting those who have recovered from infection with Ebola. [3] Symptoms include joint and muscle pain, eye problems, including blindness, various neurological problems, and other ailments, sometimes so severe that the person is unable to work. [ 4 ]